by The catheter related blood stream infection market comprises catheters coated with antimicrobial agents or antiseptics to prevent infections associated with short term and long term catheterization. Catheterization allows easy administration of fluids, medications, blood products and facilitates drainage of urine from the bladder. However, prolonged catheterization increases the risk of catheter related bloodstream infections. Catheters coated with antimicrobial agents prevent bacteria from forming biofilm on catheter surfaces thus reducing infection risk substantially. Growing geriatric population prone to various chronic illnesses necessitating catheterization is boosting demand for infection prevention solutions in the healthcare industry.
The Global Catheter Related Blood Stream Infection Market is estimated to be valued at US$ 1875.01 Mn in 2024 and is expected to exhibit a CAGR of 6.2% over the forecast period 2024 to 2031.
Key Takeaways
Key players: Key players operating in the catheter related blood stream infection market are BASF SE, Croda International plc, Emery Oleochemicals, Haihang Industry Co., Ltd, Jiangsu Senxuan Pharmaceutical and Chemical Co., Ltd., Matrica S.p.A., Nantong Hengxing Electronic Materials Co., Ltd., Nantong Jinghua Pharmaceutical Co., Ltd., Wufeng Chicheng Biotech Co., Ltd., and Xi’an Sonwu Biotech Co., Ltd.
Key opportunities: Rising awareness among patients and healthcare providers regarding advantages of anti-infective catheters is generating high demand. Furthermore, increasing R&D investments by major players for development of novel biomaterial coatings will open new growth prospects in the forecast period.
Global expansion: Major players are focused on expanding their presence in high growth markets like Asia Pacific and Latin America. These regions are expected to offer profitable opportunities owing to growing healthcare infrastructure and increasing acceptance of advanced infection control products.
Market drivers
The major driver for The Catheter Related Blood Stream Infection Market is the rising geriatric population globally which is more prone to chronic illnesses like urinary tract infection requiring long term catheterization. According to the UN, the share of global population aged 65 years and above is projected to double from 7% to 16% between 2015 and 2050. Additionally, prevalence of lifestyle diseases necessitating surgical interventions and subsequent catheter usage is also propelling market growth. Stringent regulations regarding reduction of hospital acquired infections will further boost adoption of anti-infective catheters.
PEST Analysis
Political: The development and approval process of new catheter related blood stream infection products are regulated by various regulatory agencies such as FDA in US. Stringent regulations may hamper the market growth.
Economic: Rising healthcare expenditure and increasing prevalence of hospital acquired infections are key factors driving the demand for catheter related blood stream infection products.
Social: Growing awareness about hospital acquired infections and their prevention is positively impacting the adoption of catheter related blood stream infection products.
Technological: Continuous research and development activities are encouraging technological advancements in catheter design and coating materials to reduce the risk of blood stream infections. Development of anti-microbial coated catheters is gaining traction.
The North America region is currently the largest market for catheter related blood stream infection products in terms of value. High healthcare expenditure and presence of key players in the region are driving the market growth.
The Asia Pacific region is projected to witness the fastest growth during the forecast period owing to increasing patient pool, rising healthcare investments, and growing medical tourism in countries like India and China.
The catheter related blood stream infection market in terms of value is highly concentrated in developed regions of North America and Europe. However, the market is expected to witness high growth in emerging economies of Asia Pacific and Latin America over the forecast period owing to increasing investments in healthcare infrastructure development in these regions.
